SARS-COV-2 Vaccines and Neurodegenerative Disease

Wednesday, June 2nd 2021 Written By:¬†Stephanie Seneff Originally published on Since December 2021, when several novel unprecedented vaccines against SARS-CoV-2 began to be approved for emergency use, there has been a worldwide effort to get these vaccines into the arms of as many people as possible as fast as possible. These vaccines have been developed “at warpContinue reading “SARS-COV-2 Vaccines and Neurodegenerative Disease”